Pan-tumor MRD Study
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Masz ukończone 18 lat.
- •Potwierdzono u Ciebie złośliwego raka litego, który jest jednym z badanych typów lub spełnia kryteria dla grupy „Różne Nowotwory Lite”.
- •Planowane jest leczenie, które ma na celu całkowite usunięcie nowotworu, w tym operacja.
- •Jeśli operacja już się odbyła, powinna mieć miejsce nie wcześniej niż 3 miesiące przed włączeniem do badania i przed rozpoczęciem dodatkowego leczenia.
- •Możesz swobodnie wykonywać codzienne czynności (stan sprawności 0, 1 lub 2).
- •Nie otrzymałeś żadnego systemowego leczenia obecnego nowotworu przed włączeniem do badania.
- •Zgodzisz się na udział w badaniu, w tym na pobranie próbek krwi i oddanie próbki tkanki guza.
- •Przeszedłeś wszystkie wcześniejsze terapie z powodu innych nowotworów (z wyjątkiem raka skóry niezwiązanego z czerniakiem) 3 lata lub dłużej temu.
✗ Disqualifies
- •Masz inny aktywny rak, oprócz raka skóry niezwiązanego z czerniakiem.
- •Miałeś przeszczep komórek macierzystych od obcej osoby.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (47)
Alabama Oncology
Birmingham, United States
Mohtaseb Cancer Center and Blood Disorders
Bullhead City, United States
Cancer & Blood Specialists of Arizona
Casa Grande, United States
CARTI
Little Rock, United States
Highlands Oncology Group (HOG)
Springdale, United States
Los Angeles Cancer Network (LACN)
Glendale, United States
Ventura County Hematology Oncology Specialists
Oxnard, United States
Medical Oncology Associates of San Diego (MOASD)
San Diego, United States
Medical Oncology Associates of San Diego
San Diego, United States
Stockton Hematology Oncology Med Group
Stockton, United States
The Melanoma and Skin Cancer Institute
Englewood, United States
Oncology & Hematology Associates of West Broward
Coral Springs, United States
Mid Florida Cancer Centers
Orange City, United States
Comprehensive Hematology Oncology (CHO)
St. Petersburg, United States
Piedmont Cancer Institute
Atlanta, United States
Cancer Care Specialists of Illinois (CCSI)
O'Fallon, United States
Carle Health
Urbana, United States
Cotton O'Neil Cancer Center [Stormont Vail]
Topeka, United States
Cancer Center of Kansas
Wichita, United States
Baptist Health Corbin
Corbin, United States
Baptist Health Hardin
Elizabethtown, United States
Baptist Health Lexington
Lexington, United States
Baptist Health Louisville
Louisville, United States
Pontchartrain Cancer Center
Covington, United States
Christus Health Highlands
Shreveport, United States
The Cancer & Hematology Centers (CHC)
Grand Rapids, United States
Mayo Clinic
Rochester, United States
Cox Health
Springfield, United States
Cancer Partners of Nebraska
Lincoln, United States
San Juan Oncology Associates
Farmington, United States
Guthrie Lourdes Memorial Hospital (GLMH)
Binghamton, United States
New York Cancer & Blood Specialists
Shirley, United States
Carolina Oncology Specialists
Charlotte, United States
Southeastern Medical Oncology Center (SMOC)
Goldsboro, United States
Regional Medical Oncology Center
Wilson, United States
Gabrail Cancer Center
Canton, United States
Taylor Cancer Research Center
Maumee, United States
Oklahoma Cancer Specialists and Research Institute (OCSRI)
Tulsa, United States
Oregon Health & Science University (OHSU)
Portland, United States
Lancaster General Hospital (UPenn)
Lancaster, United States
Guthrie Foundation
Sayre, United States
Cancer Care Associates of York (CCAY)
York, United States
Onocology Consultants P.A. (Oncology Consultants [OC Houston])
Houston, United States
Community Clinical Trials
Kingwood, United States
Christus St. Michael's
Texarkana, United States
Virginia Cancer Institute
Richmond, United States
Northwest Medical Specialties (NWMS)
Tacoma, United States
Trial contact
Anosheh Afghahi, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/25/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.